Delivery Order SPE2DB22D3501-SPE2DB24FVC24
Award Date 3/29/24
Potential Completion Date 4/1/24
Potential Value $3.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,578,946 units of VYVANSE 30 MG CAPSULES 100S. The $1,789.44 contract has a completion date of February 7, 2024. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 from DLA for the delivery of pharmaceutical products and medical...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to supply 4,563,151,760 units of VYVANSE 40 MG CAPSULE 100S. The $14,674.12 contract has a completion date of December 21, 2023. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor with no set-aside designation. Amerisourcebergen Drug Corp's parent company is Cencora, Inc., which does business as...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,564,183,166 units of VYVANSE 30 MG CAPSULE 100S. The contract has a ceiling value of $2,155.00 and an ultimate completion date of April 8, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract with DLA valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,647,521 units of VYVANSE 30 mg capsules. The $5,470.48 contract, awarded on February 13, 2024, has a completion date of February 14, 2024 and does not use any set-aside designation. Amerisourcebergen Drug Corp, as the prime contractor, will fulfill this order...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the delivery of VYVANSE 30 mg capsules. The contract has a potential value of $1,563.77 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor, and the contract was awarded without any set-aside designation. In addition to this specific delivery order, Amerisourcebergen Drug Corp...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,743,165 units of the pharmaceutical product VYVANSE 40 MG CAPSULE 100S. The $1,724.00 contract has a completion date of February 23, 2024 and was awarded on February 22, 2024. Amerisourcebergen Drug Corp is the prime contractor for this order, which is not associated with a set-aside designation....
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,982,057 units of VYVANSE 50 MG CAPSULE 100S. The award, valued at $2,616.61, has an ultimate completion date of March 18, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31,...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,322,270 units of the pharmaceutical product VYVANSE 30 MG CAPSULE 100S. The award, valued at $7,063.09, has a completion date of January 10, 2024. Amerisourcebergen Drug Corp is a prime contractor that has previously received numerous federal contract awards from DLA to supply pharmaceuticals, medical supplies, and related...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,692,509 units of VYVANSE 30 mg capsules. The contract has a completion date of February 20, 2024 and a potential value of $1,357.00. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order and does not have any major subcontractors noted. The contract does not have a...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,471,651 units of the prescription drug VYVANSE 30 MG CAPSULE. The order has a total potential value of $2,373.57 and a completion date of January 26, 2024. Amerisourcebergen Drug Corp is the prime contractor for this award, which is not designated as a set-aside contract. This delivery order is part of a larger indefinite...